Related Experiment Video
Updated: Jan 27, 2026

Ex Vivo Infection of Live Tissue with Oncolytic Viruses
Published on: June 25, 2011
Oncolytic adenoviruses: a game changer approach in the battle between cancer and the immune system
Victor Cervera-Carrascon1,2, Riikka Havunen1,2, Akseli Hemminki1,2,3
1a Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine , University of Helsinki , Helsinki , Finland.
Introduction:
Oncolytic adenoviruses are among the most studied oncolytic viruses because of their tumor selectivity, safety, and transgene-delivery capability. With a growing number of different immunotherapies against cancer, the extraordinary immunogenicity of the adenovirus has emerged as a differentiating strength. Enabling T-cell related therapies with oncolytic adenoviruses appears a promising approach due to its inherent ability to elicit responses from the adaptive immune compartment.
Areas Covered:
These viruses have successfully enhanced both adoptive T-cell therapies and immune-checkpoint therapies. Oncolytic viruses induce several effects at the tumor and on the systemic level that help to circumvent current limitations of T-cells and related therapies, such as T-cell trafficking, tumor immune suppressivity and antigen spreading
Expert Opinion:
Taking into account the multitude of possibilities of treating cancer with immunotherapies, learning to optimize the combinations and administration strategies of these drugs, could lead to durable responses in patients with currently incurable cancers.
Insights
Oncolytic adenoviruses enhance cancer immunotherapy by boosting T-cell responses. Their immunogenicity and ability to overcome T-cell limitations offer a promising strategy for treating difficult cancers.
Area of Science:
- Oncolytic virotherapy
- Cancer immunotherapy
- Adenovirus research
Background:
- Oncolytic adenoviruses are highly studied for cancer treatment due to tumor selectivity, safety, and gene delivery.
- Adenoviruses possess strong immunogenicity, making them valuable for immunotherapy.
- They can elicit adaptive immune responses, crucial for T-cell related therapies.
Purpose of the Study:
- To explore the potential of oncolytic adenoviruses in enhancing cancer immunotherapies.
- To highlight the role of adenovirus immunogenicity in T-cell mediated cancer treatment.
- To discuss how oncolytic viruses can overcome current limitations in T-cell therapies.
Main Methods:
- Review of current research on oncolytic adenoviruses and their application in cancer immunotherapy.
- Analysis of adenovirus-induced effects on tumor microenvironment and systemic immunity.
- Examination of strategies to combine oncolytic adenoviruses with adoptive T-cell and immune-checkpoint therapies.
Main Results:
- Oncolytic adenoviruses have shown success in augmenting adoptive T-cell and immune-checkpoint therapies.
- These viruses induce systemic and local effects that improve T-cell function.
- They help address challenges like T-cell trafficking, tumor immune suppression, and antigen spreading.
Conclusions:
- Optimizing combinations and administration of oncolytic adenoviruses with other immunotherapies can lead to durable responses.
- Oncolytic adenoviruses represent a promising platform for advancing cancer treatment.
- Further research into combination strategies could unlock new possibilities for incurable cancers.
More Related Videos
07:13Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer
Published on: March 26, 2014
06:29Modeling Breast Cancer via an Intraductal Injection of Cre-expressing Adenovirus into the Mouse Mammary Gland
Published on: June 7, 2019
Related Concept Videos
What is the Immune System?
Social Foundations of Self I: Play and Game
Humoral Immune Responses
Frustration and Conflict: Approach-Approach, Approach-Avoidance
One common type of conflict is the Approach–Approach Conflict. In this case, a person faces two desirable...
Active versus Passive Immunity
Active Immunity
Active immunity refers to the resistance one develops...
Introduction to Lymphatic and Immune System
The immune responses can be categorized into two types: innate and adaptive. Innate immunity comprises nonspecific defenses we are...